Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...

The effects appeared to rely on more than just improved in blood sugar control or weight reduction, the authors said, and ...

And actually, as the GLP-1s have actually continued to expand throughout the community, that’s where many of the initial ...

With only one approved drug on the market, companies like Inventiva Pharma are advancing MASH drugs and seeking a competitive ...

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...

It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

"Metformin was associated with a lowered risk of asthma attacks by approximately 30%," the researchers found. When patients ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

The efficacy of GLP-1s has made them a breakthrough not only in managing obesity and diabetes, but also in their potential to ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

Only 13 states currently offer Medicaid coverage for GLP-1 drugs, but the number of prescriptions and overall spending has ...

Still, gross spending on the drugs increased by more than 500% from 2019 to 2023, according to the health policy research ...